Relying on at-home tests alone may delay diagnosis of more serious gastrointestinal diseases. Taking an at-home test for ...
Clinical study results show patients who eliminated foods as determined by the inFoods® IBS test experience significant improvement in IBS Symptoms Including Abdominal Pain Intensity (API) IRVINE, ...
Biomerica, Inc. announced that the American Medical Association's CPT editorial panel has granted a Proprietary Laboratory Analysis (PLA) code for its inFoods® IBS test, which personalizes the ...
Biomerica applies for a PLA code to enhance patient access to its inFoods IBS diagnostic test for personalized IBS management. Biomerica, Inc. has submitted an application to the American Medical ...
Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...
The inFoods ® IBS test is a novel, non-invasive diagnostic that identifies patient-specific IBS trigger foods that may be contributing to IBS symptoms such as bloating, abdominal pain, diarrhea, and ...
An elimination diet guided by a novel irritable bowel syndrome (IBS)–specific immunoglobulin G (IgG) assay reduced abdominal pain in a greater proportion of patients with IBS than a sham elimination ...
The test identifies specific foods that provoke an abnormal immune response, believed to be a key trigger of IBS symptoms. “This publication in Gastroenterology reinforces the scientific rigor, ...
inFoods IBS showed improvement in API similar to, and in some cases better than, current IBS drugs in the market NEWPORT BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), ...
The 59.4% real-world pain responder rate from the use of inFoods® IBS closely mirrors the 59.6% result from the controlled trial—offering an unusual degree of consistency between controlled and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results